Skip to main content
. 2021 Jun 10;4(7):e202000999. doi: 10.26508/lsa.202000999

Figure S3. Brefeldin A treatment does not prevent suppression of cord T-cell cytokine production resulting from exposure to invariant natural killer T cells and monocytes.

Figure S3.

Isolated CD4+ cord blood T cells were cultured for 5 d with autologous monocytes alone, or with autologous monocytes and invariant natural killer T cells. Where indicated, the monocytes were pretreated with brefeldin A (BfA) or vehicle (veh) before being added to the co-cultures.